|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00773006 |
|
Date of registration:
|
28/01/2008 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Canadian Anticoagulant Percutaneous Coronary Intervention Registry
CAPCIR |
|
Scientific title:
|
Canadian Prospective, Observational Study on the Use of LMWH in the Setting of Percutaneous Coronary Intervention |
|
Date of first enrolment:
|
February 2008 |
|
Target sample size:
|
747 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00773006 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. 18 or more years of age.
2. Undergoing PCI during treatment with LMWH
3. Provision of written and informed consent
Exclusion Criteria:
1. Language, medical, or psychiatric barriers that preclude understanding of informed
consent process.
2. Patients in which the site investigator is unable to comply with completion of study
documentation following PCI, i.e. patients with planned transfer to another hospital
not participating in the registry.
3. Enrollment in a clinical trial involving another anticoagulant agent.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Coronary Artery Disease
|
|
Primary Outcome(s)
|
|
Description of anticoagulant management during PCI and current practices of participating centres will be undertaken
[Time Frame: in-hospital]
|
|
Secondary Outcome(s)
|
|
In-hospital safety outcomes including - major, minor bleeding, requirement for transfusion, death, myocardial infarction (or re-MI), myocardial ischemia requiring urgent revascularization, and major bleeding
[Time Frame: in-hospital]
|
|
In-hospital angiographic complications: no reflow, thrombus, occlusion of collateral branches, distal embolism, coronary dissection, acute closure of the culprit vessel
[Time Frame: in-hospital]
|
|
PCI-related resources utilization during the study period, including cost of PCI and its treatment (e.g. duration of hospital stay, drug costs, costs related to bleeding such as transfusions)
[Time Frame: in-hospital]
|
|
Secondary ID(s)
|
|
CAPCIR02474
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|